Jinbo Yue
Clinical trials sponsored by Jinbo Yue, explained in plain language.
-
New combo therapy aims to shrink bile duct tumors before surgery
Disease control Recruiting nowThis study tests a new approach for people with a type of bile duct cancer that is difficult to remove with surgery. Participants receive a combination of targeted radiation, immunotherapy (tislelizumab), and chemotherapy before any surgery. The goal is to shrink the tumor enough…
Phase: PHASE2 • Sponsor: Jinbo Yue • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
New combo therapy targets stomach Cancer's hidden spread
Disease control Recruiting nowThis study tests whether adding surgery and radiation to standard chemotherapy can improve outcomes for people with stomach cancer that has spread to specific lymph nodes in the back of the abdomen. About 54 participants will receive either standard treatment or a combination of …
Phase: PHASE2 • Sponsor: Jinbo Yue • Aim: Disease control
Last updated May 15, 2026 11:57 UTC